Lifecore Biomedical Inc (LFCR)
6.40
-0.28
(-4.19%)
USD |
NASDAQ |
Nov 15, 16:00
6.41
+0.01
(+0.16%)
After-Hours: 20:00
Lifecore Biomedical Free Cash Flow (Quarterly): -4.035M for Aug. 31, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| August 31, 2024 | -4.035M |
| May 31, 2024 | 6.003M |
| February 29, 2024 | -7.785M |
| November 30, 2023 | -2.973M |
| August 31, 2023 | -13.38M |
| May 31, 2023 | -9.435M |
| February 28, 2023 | -18.82M |
| November 30, 2022 | -6.201M |
| August 31, 2022 | -4.462M |
| May 31, 2022 | -11.95M |
| February 28, 2022 | -23.27M |
| November 30, 2021 | -10.23M |
| August 31, 2021 | -7.082M |
| May 31, 2021 | -7.969M |
| February 28, 2021 | -11.83M |
| November 30, 2020 | -1.349M |
| August 31, 2020 | 12.40M |
| May 31, 2020 | -17.27M |
| February 29, 2020 | 4.495M |
| November 30, 2019 | -15.53M |
| August 31, 2019 | -15.42M |
| May 31, 2019 | -13.02M |
| February 28, 2019 | -1.91M |
| November 30, 2018 | -1.531M |
| August 31, 2018 | -12.25M |
| Date | Value |
|---|---|
| May 31, 2018 | -13.38M |
| February 28, 2018 | 2.666M |
| November 30, 2017 | -0.824M |
| August 31, 2017 | -2.277M |
| May 31, 2017 | -6.858M |
| February 28, 2017 | 12.90M |
| November 30, 2016 | -3.547M |
| August 31, 2016 | 4.336M |
| May 31, 2016 | 0.796M |
| February 29, 2016 | -6.808M |
| November 30, 2015 | -7.669M |
| August 31, 2015 | -5.252M |
| May 31, 2015 | 5.933M |
| February 28, 2015 | 6.959M |
| November 30, 2014 | -3.63M |
| August 31, 2014 | -0.155M |
| May 31, 2014 | 2.517M |
| February 28, 2014 | 7.03M |
| November 30, 2013 | -3.581M |
| August 31, 2013 | 0.193M |
| May 31, 2013 | 3.416M |
| February 28, 2013 | 9.833M |
| November 30, 2012 | -3.952M |
| August 31, 2012 | 3.056M |
| May 31, 2012 | 12.17M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-23.27M
Minimum
Feb 2022
12.40M
Maximum
Aug 2020
-7.534M
Average
-7.877M
Median
Free Cash Flow (Quarterly) Benchmarks
| AngioDynamics Inc | -19.34M |
| Precision Optics Corp Inc | -0.9878M |
| Sage Therapeutics Inc | -82.36M |
| Outset Medical Inc | -20.96M |
| NovaBay Pharmaceuticals Inc | -2.063M |